Raleigh eyecare startup lands nearly $5M from investors
A young Raleigh startup developing a non-prescription eyedrop to treat dry eye syndrome says it has raised $4.9 million in an oversubscribed Series A round of funding.
Read MorePosted by WRAL TechWire | Oct 7, 2020
A young Raleigh startup developing a non-prescription eyedrop to treat dry eye syndrome says it has raised $4.9 million in an oversubscribed Series A round of funding.
Read MorePosted by WRAL News | May 27, 2020
One UNC-affiliated startup is looking to help those with dry eye lead better lives through its product EternaTear, an artificial tear that is being designed to last much longer than other OTC treatments.
Read MorePosted by WRAL TechWire | Apr 13, 2020
EternaTear, which is developing a therapy for dry eye using a novel and proprietary mechanism to supplement all three layers of the tear film and bind them together on the ocular surface, is looking to raise $4 million.
Read More